NDCFind

Xarelto 50458-0575

Generic: Rivaroxaban

Product NDC

50458-0575
Manufacturer
Janssen Pharmaceuticals, Inc.
Dosage Form
Granule, For Suspension
Route
Oral
Product Type
Human Prescription Drug
Marketing Start
December 1, 2021
Listing Expires
December 31, 2027
Application
NDA215859
StockMeds — pharmacy-to-pharmacy marketplace

Need to source Xarelto? P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

IngredientStrength
Rivaroxaban155 mg/1

Drug Class

Factor Xa Inhibitor [EPC]Factor Xa Inhibitor [EPC]Factor Xa Inhibitors [MoA]

Packaging Options(1)

1 BOTTLE in 1 CARTON (50458-575-01) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE